Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sarah Frye

1PUBLICATIONS

15CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 13, 2024

Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate.

Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker

Pageof 1

Frequent Collaborators

1 joint publications

Jessica Pougoue Ketchemen

1 joint publications

Fabrice Ngoh Njotu

1 joint publications

Hanan Babeker

1 joint publications

Alissar Monzer

1 joint publications

Emmanuel Nwangele

1 joint publications

Anjong Florence Tikum

1 joint publications

Nikita Henning

1 joint publications

Nava Hassani

1 joint publications

Randy Perron

1 joint publications

Chris Byrne

Frequent Collaborators

1 joint publications

Jessica Pougoue Ketchemen

1 joint publications

Fabrice Ngoh Njotu

1 joint publications

Hanan Babeker

1 joint publications

Alissar Monzer

Top Related Videos

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

See more related videos

Top Related Videos

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

See more related videos